The news of Thiel’s investment sent ETHZilla’s stock price soaring by more than 200% in a single session. The company’s shares are currently trading at around $10.24, reflecting a whopping 206.6% gain in just the past 24 hours. With a market capitalization of about $1.58 billion, ETHZilla has seen its value skyrocket over the past week due to this major pivot into cryptocurrency and Thiel’s investment.
Unlike other biotech firms that have survived through licensing deals or buyouts, ETHZilla has fully embraced Ethereum. The company is not just holding onto its ETH but also using it through advanced on-chain strategies such as staking, lending, and liquidity provisioning. These strategies are aimed at generating returns beyond simple appreciation. To manage this treasury like a revenue-generating asset, ETHZilla has set up a dedicated DeFi Council of seasoned capital markets professionals and blockchain innovators.
